A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Hackensack Meridian Health
Takeda
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
City of Hope Medical Center
Incyte Corporation
Incyte Corporation
Incyte Corporation
Incyte Corporation
PharmaEssentia Japan K.K.
Weill Medical College of Cornell University
Incyte Corporation
Celgene
City of Hope Medical Center
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Weill Medical College of Cornell University
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
City of Hope Medical Center
Celgene
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Pfizer
Incyte Corporation
City of Hope Medical Center
Stanford University
Washington University School of Medicine
University of Nebraska
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
University of Washington
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Incyte Corporation
Medical College of Wisconsin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Takeda